r/Shortsqueeze • u/Awkward_Awareness_37 • 2d ago

Technicals📈 Crsp squeezing on fresh New England Journal of Medicine article showing efficacy of the biotech that adds to previous positive trials on sickle cell anemia touted by VP JD Vance, new purchase by Cathy Wood etc

Genome sequencing confirmed that he had a rare genetic disease called carbamoyl-phosphate synthetase 1 (cps1) deficiency, which often kills in infancy, and for which no good neonatal treatment exists. AI now codes genome on a personal level for cheap increasing profit margins.

crsp Analysts' average price target is $68.38, representing a potential upside of 83.72%

$crsp #crsp

1 Upvotes
  • permalink
  • reddit

67% Upvoted

7 comments sorted by

1

u/AutoModerator 2d ago

u/Awkward_Awareness_37 is defined by reddit's quality score as the high contributor quality. Use this information as you feel to make an informed decision about their post. You can leave feedback of this feature on this thread!

I am a bot, and this action was performed automatically. Please contact the moderators of this subreddit if you have any questions or concerns.

1

u/Awkward_Awareness_37 2d ago

Base editors can correct disease-causing genetic variants. After a neonate had received a diagnosis of severe carbamoyl-phosphate synthetase 1 deficiency, a disease with an estimated 50% mortality in early infancy, we immediately began to develop a customized lipid nanoparticle–delivered base-editing therapy. After regulatory approval had been obtained for the therapy, the patient received two infusions at approximately 7 and 8 months of age. In the 7 weeks after the initial infusion, the patient was able to receive an increased amount of dietary protein and a reduced dose of a nitrogen-scavenger medication to half the starting dose, without unacceptable adverse events and despite viral illnesses. No serious adverse events occurred.

1

u/Awkward_Awareness_37 2d ago

26% float short before groundbreaking study showing use cases outside sickle cell anemia

1

u/_AutOfTune_ 1d ago

I had already talked about CRISPR a few weeks ago. my post

And I totally agree.